Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, Lerner S, LaPushin R, Xiao L, Huang X, Werner L, Neuberg D, Kantarjian H, O'Brien S, Wierda WG, Keating MJ, Rosenwald A, Burger JA. Sivina M, et al. Among authors: lapushin r. Blood. 2011 Feb 3;117(5):1662-9. doi: 10.1182/blood-2010-09-307249. Epub 2010 Nov 29. Blood. 2011. PMID: 21115978 Free PMC article.
Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC.
Decker WK, Shah N, Xing D, Lapushin R, Li S, Robinson SN, Yang H, Parmar S, Halpert MM, Keating MJ, Gribben JG, Molldrem JJ, Shpall EJ, Wierda WG. Decker WK, et al. Among authors: lapushin r. PLoS One. 2012;7(12):e51390. doi: 10.1371/journal.pone.0051390. Epub 2012 Dec 19. PLoS One. 2012. PMID: 23284688 Free PMC article.
HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance.
Shah N, Decker WK, Lapushin R, Xing D, Robinson SN, Yang H, Parmar S, Tung SS, O'Brien S, Fernandez-Viña M, Shpall EJ, Wierda WG. Shah N, et al. Among authors: lapushin r. Leukemia. 2011 Jun;25(6):1036-9. doi: 10.1038/leu.2011.30. Epub 2011 Feb 25. Leukemia. 2011. PMID: 21350559 No abstract available.
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.
Mills GB, Eder A, Fang X, Hasegawa Y, Mao M, Lu Y, Tanyi J, Tabassam FH, Wiener J, Lapushin R, Yu S, Parrott JA, Compton T, Tribley W, Fishman D, Stack MS, Gaudette D, Jaffe R, Furui T, Aoki J, Erickson JR. Mills GB, et al. Among authors: lapushin r. Cancer Treat Res. 2002;107:259-83. doi: 10.1007/978-1-4757-3587-1_12. Cancer Treat Res. 2002. PMID: 11775454 Review.
The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL, Morris AJ, Wolf JK, Fang X, Hasegawa Y, Lapushin R, Auersperg N, Sigal YJ, Newman RA, Felix EA, Atkinson EN, Mills GB. Tanyi JL, et al. Among authors: lapushin r. Cancer Res. 2003 Mar 1;63(5):1073-82. Cancer Res. 2003. PMID: 12615725
45 results